Xiaoxi Zhou

Tongji University — China

Medicine · Health Sciences

25h-index2.5kcitations77works9.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(34), Lymphoma Diagnosis and Treatment(13), Virus-based gene therapy research(9), Multiple Myeloma Research and Treatments(7), Immune Cell Function and Interaction(7)

Publications77 total

Practice pattern and outcomes in DLBCL by Genetic Subtypes: Preliminary results from a large-scale real-world study in China
Blood·2025Open Access
Durable response of primary cardiac lymphoma after autologous stem cell transplantation and sequential CAR-T therapy: a case report and literature review
Frontiers in Immunology·2025· 2 citedOpen Access
Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma
Journal of Translational Medicine·2025· 6 citedOpen Access
Effect of neuromuscular electrical stimulation combined with respiratory rehabilitation training on pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
Journal of Cardiothoracic Surgery·2025· 3 citedOpen Access
A successful haploidentical transplantation without conditioning regimen for a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T-cell therapy
Cytotherapy·2024
CD19/CD22 CAR-T-cell cocktail therapy following autologous transplantation is an optimizing strategy for treating relapsed/refractory central nervous system lymphoma
Experimental Hematology and Oncology·2024· 5 citedOpen Access
Hepatitis B virus reactivation associated with CAR T-cell therapy
Holistic Integrative Oncology·2024· 3 citedOpen Access
The link between ten-eleven translocation-2 (Tet2) related clonal hematopoiesis and sequential onset of two hematologic malignancies
Genes & Diseases·2024Open Access
EBV-associated lymphoproliferative disease post-CAR-T cell therapy
Frontiers of Medicine·2024· 9 cited
A single‐centre, real‐world study of <scp>BTK</scp> inhibitors for the initial treatment of <scp>MYD88<sup>mut</sup></scp>/<scp>CD79B<sup>mut</sup></scp> diffuse large B‐cell lymphoma
Cancer Medicine·2024· 12 citedOpen Access
Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis
Redox Biology·2024· 60 citedOpen Access
Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma
Frontiers in Immunology·2023· 8 citedOpen Access
Phase 1 Dose Escalation Study of the Anti-CD7 CAR-T Therapy in Relapsed/Refractory T-Cell Acute Leukemia and Lymphoblastic Lymphoma
Blood·2023· 2 cited
CD19/CD22 CAR T-Cell Therapy Following Autologous Transplantation Is an Optimizing Strategy in Relapsed/Refractory Central Nervous System Lymphoma
Blood·2023Open Access
Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients
Blood·2023· 1 cited
[Characteristics and impact factors of SARS-CoV-2 infection in adult patients with relapsed/refractory B-cell non-Hodgkin lymphoma receiving chimeric antigen receptor T-cell therapy].
PubMed·2023Open Access
Functional diversification and dynamics of CAR-T cells in patients with B-ALL
Cell Reports·2023· 4 citedOpen Access
[A case of Hb M-Iwate combined with diffuse large B-cell lymphoma].
PubMed·2023Open Access
Experimental observation of anomalous optical transmission in interlaced metallic wire meshes
arXiv (Cornell University)·2023Open Access
Loading neural stem cells on hydrogel scaffold improves cell retention rate and promotes functional recovery in traumatic brain injury
Materials Today Bio·2023· 35 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Jianfeng Zhou(26), Liang Huang(17), Liting Chen(16), Yang Cao(13), Chunrui Li(13), Xia Mao(11), Jue Wang(11), Min Xiao(11), Qiangying Yi(10), Yao Wu(10), Tongjuan Li(9), Na Wang(8), Zhenya Hong(8), Gaoxiang Wang(7), Lijun Jiang(6), Di Wang(6), Yi Xiao(6), Ke Kang(6), Shangkun Zhang(5), Yicheng Zhang(5)